Neuropsychological and neurobiological markers of the preclinical stage of alzheimer's disease

Psychology and Neuroscience

Volumn 4, Issue 2, 2011, Pages 245-253

  Fichman, Helenice Charchat ^a   Oliveira, Rosinda Martins ^b   Fernandes, Conceição Santos ^c  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Alzheimer's disease; Dementia; Longitudinal studies; Neurobiological markers

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN METABOLISM; BRAIN PERFUSION; BRAIN SIZE; DEMENTIA; HUMAN; MEMORY DISORDER; NEUROBIOLOGY; NEUROFIBRILLARY TANGLE; NEUROPSYCHOLOGY; RISK FACTOR; SENILE PLAQUE;

EID: 83655181059     PISSN: 19843054     EISSN: 19833288     Source Type: Journal    
DOI: 10.3922/j.psns.2011.2.010     Document Type: Article

References (124)

1. Albert, M.S., Villainy, R.J., Johnson, K., Tanzi, R.E., & Jones, K. (2001). Preclinical prediction of AD: relation between neuropsychological and neuroimaging fndings. In K. Iqbal, S.S. Sisodia, & B. Winblad (Eds.), Alzheimer's disease: advances in etiology, pathogenesis and therapeutics (pp. 97-98). New York: John Wiley.
2. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders. 4th edition. Washington, D.C.: American Psychiatric Press.
3. Andreasen, N., Minthon, L., Davidsson, P., Vanmechelen, E., Vanderstichele, H., Winblad, B., & Blennow, K. (2001). Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice. Archives of Neurology, 58, 373-379.
4. Anstey, K.J., Cherbuin, N., Christensen, H., Burns, R., Reglade-Meslin, C., Salim, A., Kumar, R., Jorm, A.F., & Sachdev, P. (2008). Follow-up of mild cognitive impairment and related disorders over four years in adults in their sixties: the PATH Through Life Study. Dementia and Geriatric Cognitive Disorders, 26, 226-233.
5. Apostolova, L.G., Dinov, I.D., Dutton, R.A., Hayashi, K.M., Toga, A.W., Cummings, J.L., & Thompson, P.M. (2006). 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease. Brain, 129, 2867-2873.
6. Argimon, I.I.L., & Stein, L.M. (2005). Habilidades cognitivas em indivíduos muito idosos: um estudo longitudinal. Caderno Saúde Pública, 21(1), 64-72.
7. Bäckman, L., Jones, S., Berger, A.K., Laukka, E.J., & Small, B.J. (2005). Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. Neuropsychology, 19(4), 520-531.
8. Baddeley, A. (1995). Working memory. In M.S. Gazzaniga (Ed.), The cognitive neurosciences (pp. 755-764). Cambridge, MA: MIT Press.
9. Baddeley, A.D. (1996). The fractionation of working memory. Proceedings of the National Academy of Sciences of the United States of America, 93, 13468-13472.
10. Banhato, E.F.C., & Nascimento, E. (2007). Função executiva em idosos: um estudo utilizando subtestes da Escala WAIS-III. PsicoUSF, 12(1), 65-73.
11. Bennett, D.A., Schneider, J.A., Bienias, J.L., Evans, D.A., & Wilson, R.S. (2005). Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology, 64, 834-841.
12. Blacker, D., Lee, H., Muzikansky, A., Martin, E.C., Tanzi, R., & McArdle, J.J., Moss, M. & Albert, M. (2007). Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Archives of Neurology, 64, 862-871.
13. Bondi, M.W., Jak, A.J., Delano-Wood, L., Jacobson, M.W., Delis, D.C., & Salmon, D.P. (2008). Neuropsychological contributions to the early identifcation of Alzheimer's disease. Neuropsychological Review, 18(1), 73-90.
14. Bottino, C.M., Castro, C.C., Gomes, R.L., Buchpiguel, C.A., Marchetti, R.L., & Neto, M.R. (2002). Volumetric MRI measurements can differentiate Alzheimer's disease, mild cognitive impairment, and normal aging. International Psychogeriatrics, 14, 59-72.
15. Bozoki, A., Giordani, B., Heidebrink, J.L., Berent, S., & Foster, N.L. (2001). Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Archives of Neurology, 58, 411-416.
16. Busse, A., Hensel, A., Guhne, U., Angermeyer, M.C., & Riedel-Heller, S.G. (2006). Mild cognitive impairment: long-term course of four clinical subtypes. Neurology, 67, 2176-2185.
17. Camarano, A.A. (2004). Os novos idosos brasileiros: muito além dos 60 anos. Rio de Janeiro: IPEA.
18. Caracciolo, B., Palmer, K., Monastero, R., Winblad, B., Backman, L., & Fratiglioni, L. (2008). Occurrence of cognitive impairment and dementia in the community: a 9-year-long prospective study. Neurology, 70, 1778-1785.
19. Chaves, M.L., Camozzato, A.L., Godinho, C., Piazenski, I., & Kaye, J. (2009). Incidence of mild cognitive impairment and Alzheimer disease in southern Brazil. Journal of Geriatric Psychiatry and Neurology, 22, 181-187.
20. Chetelat, G., Landeau, B., Eustache, F., Mezenge, F., Viader, F., de la Sayette, V., Desgranges, B., & Baron, J.C. (2005). Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Neuroimage, 27, 934-946.
21. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L., & Pericak-Vance, M.A. (1993). Gene dose of apoliprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science, 261, 921-923.
22. Crook, T., Bartus, R.T., Ferris, S.H., Whitehouse, P., Cohen, G.D., & Gershon, S. (1986). Age associated memory impairment: proposed diagnostic criteria and measures of clinical change: report of a National Institute of Mental Health work group. Development Neuropsychology, 2, 261-276.
23. Daly, E., Zaitchik, D., Copeland, M., Schmahmann, J., Gunther, J., & Albert, M. (2000). Predicting conversion to Alzheimer disease using standardized clinical information. Archives of Neurology, 57, 675-680.
24. Das, S.K., Bose, P., Biswas, A., Dutt, A., Banerjee, T.K., Hazra, A.M., Raut, D.K., & Roy, T. (2007). An epidemiologic study of mild cognitive impairment in Kolkata, India. Neurology, 68, 2019-2026.
25. Davatzikos, C., Xu, F., An, Y., Fan, Y., & Resnick, S.M. (2009). Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index. Brain, 132, 2026-2035.
26. Devanand, D.P., Liu, X., Tabert, M.H., Pradhaban, G., Cuasay, K., Bell, K., de Leon, M.J., Doty, R.L., Stern, Y., & Pelton, G.H. (2008). Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biological Psychiatry, 64, 871-879.
27. Di Carlo, A., Lamassa, M., Baldereschi, M., Inzitari, M., Scafato, E., Farchi, G., & Inzitari, D. (2007). CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia. Neurology, 68, 1909-1916.
28. Dickerson, B.C., Salat, D.H., Greve, D.N., Chua, E.F., Rand-Giovannetti, E., Rentz, D.M., Bertram, L., Mullin, K., Tanzi, R.E., Blacker, D., Albert, M.S., & Sperling, R.A. (2005). Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology, 65, 404-411.
29. Diniz, B.S., Pinto Juñior, J.A., & Forlenza, O.V. (2008). Do CSF total tau, phosphorylated tau, and β-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature. World Journal of Biological Psychiatry, 9, 172-182.
30. Driscoll, I., Howard, S.R., Prusky, G.T., Rudy, J.W., & Sutherland, R.J. (2005). Seahorse wins all races: hippocampus participates in both linear and non-linear visual discrimination learning. Behavioural Brain Research, 164, 29-35.
31. Du, A.T., Schuff, N., Amend, D., Laakso, M.P., Hsu, Y.Y., Jagust, W.J., Yaffe, K., Kramer, J.H., Reed, B., Norman, D., Chui, H.C., & Weiner, M.W. (2001). Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry, 71, 441-447.
32. Duchek, J.M., Balota, D.A., Tse, C.S., Holtzman, D.M., Fagan, A.M., & Goate, A.M. (2009). The utility of intraindividual variability in selective attention tasks as an early marker for Alzheimer's disease. Neuropsychology, 23, 746-758.
33. Elias, M.F., Beiser, A., Wolf, P.A., Au, R., White, R.F., & D'Agostino, R.B. (2000). The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham Cohort. Archives of Neurology, 57, 808-813.
34. Fabrigoule, C., Rouch, I., Taberly, A., Letenneur, L., Commenges, D., Mazaux, J.M., Orgogozo, J.M., & Dartigues, J.F. (1998). Cognitive process in preclinical phase of dementia. Journal of Neurology, 121, 135-141.
35. Farias, S.T., Mungas, D., Reed, B.R., Harvey, D., & DeCarli, C. (2009). Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Archives of Neurology, 66, 1151-1157.
36. Fennema-Notestine, C., McEvoy, L.K., Hagler, D.J., Jr., Jacobsona, M.W., & Daleb, A.M. (2009). Structural neuroimaging in the detection and prognosis of preclinical and early AD. Behavioural Neurology, 21(1), 3-12.
37. Fischer, P., Jungwirth, S., Zehetmayer, S., Weissgram, S., Hoenigschnabl, S., Gelpi, E., Krampla, A., & Tragl, K.H. (2007). Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology, 68, 288-291.
38. Forlenza, O.V., Diniz, B.S., Talib, L.L., Radanovic, M., Yassuda, M.S., Ojopi, E.B., & Gattaz, W.F. (2010). Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment. Revista Brasileira de Psiquiatria, 32, 216-222.
39. Ganguli, M., Dodge, H.H., Shen, C., & DeKosky, S.T. (2004). Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology, 63, 115-121.
40. Gauthier, S., Reisberg, B., Zaudig, M., Petersen, R.C, Ritchie, K., Broich, K., Belleville, S., Brodaty, H., Bennett, D., Chertkow, H., Cummings, J.L., de Leon, M., Feldman, H., Ganguli, M., Hampel, H., Scheltens, P., Tierney, M.C., Whitehouse, P., & Winblad, B. (2006). Mild cognitive impairment. Lancet, 367, 1262-1270.
41. Greenwood, K., Williams, T., & Geary, T. (2005). Nematode neuropeptide receptors and their development as anthelmintic screens. Parasitology, 131 Suppl., S169-S177.
42. Hämäläinen, A., Tervo, S., Grau-Olivares, M., Niskanen, E., Pennanen, C., Huuskonen, J., Kivipelto, M., Hanninen, T., Tapiola, M., Vanhanen, M., Hallikainen, M., Helkala, E.L., Nissinen, A., Vanninen, R., & Soininen, H. (2007). Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment. Neuroimage, 37, 1122-1131.
43. Hänninen, T., Hallikainen, M., Tuomainen, S., Vanhanen, M., & Soininen, H. (2002). Prevalence of mild cognitive impairment: a population-based study in elderly subjects. Acta Neurologica Scandinava, 106, 148-154.
44. Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K., & Minthon, L. (2006). Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurology, 5, 228-234.
45. Hinrichs, C., Singh, V., Xu, G., & Johnson, S.C. (2011). Predictive markers for AD in a multi-modality framework: an analysis of MCI progression in the ADNI population. Neuroimage, 55, 574-589.
46. Jack, C.R., Jr., Petersen, R.C., Xu, Y.C., Waring, S.C., O'Brien, P.C., Tangalos, E.G., Smith, G.E., Ivnik, R.J., & Kokmen, E. (1997). Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology, 49, 786-794.
47. Jacobson, M.W., Delis, D.C., Lansing, A., Houston, W., Olsen, R., Wetter, S., Bondi, M.W., & Salmon, D.P. (2005). Asymmetries in global-local processing ability in elderly people with the apolipoprotein e-e4 allele. Neuropsychology, 19, 822-829.
48. Johnson, S.C., Baxter, L.C., Susskind-Wilder, L., Connor, D.J., Sabbagh, M.N., & Caselli, R.J. (2004). Hippocampal adaptation to face repetition in healthy elderly and mild cognitive impairment. Neuropsychologia, 42, 980-989.
49. Johnson, S.C., Schmitz, T.W., Moritz, C.H., Meyerand, M.E., Rowley, H.A., Alexander, A.L., Hansen, K.W., Gleason, C.E., Carlsson, C.M., Ries, M.L., Asthana, S., Chen, K., Reiman, E.M., & Alexander, G.E. (2006). Activation of brain regions vulnerable to Alzheimer's disease: the effect of mild cognitive impairment. Neurobiology of Aging, 27, 1604-1612.
50. Kalache, A. (1991). Ageing is a third world problem too. International Journal of Geriatric Psychiatry, 6, 617-618.
51. Kalache, A., Veras, R.P., & Ramos, L.R. (1987). The aging of the world population: a new challenge. Revista de Saude Publica, 21, 200-210.
52. Killiany, R.J., Gomez-Isla, T., Moss, M., Kikinis, R., Sandor, T., Jolesz, F., Tanzi, R., Jones, K., Hyman, B.T., & Albert, M.S. (2000). Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Annals of Neurology, 47, 430-439.
53. Kral, V.A. (1962). Senescent forgetfulness: benign and malignant. Canadian Medical Association Journal, 86, 257-260.
54. Levy, R. (1994). Aging-associated cognitive decline. International Psychogeriatric, 6, 63-68 [erratum: 6(2), 133].
55. Linn, R.T., Wolf, P.A., Bachman, D.L., Knoefel, J.E., Cobb, J.L., Belanger, A.J., Kaplan, E.F., & D'Agostino, R.B. (1995). The "preclinical phase" of probable Alzheimer's disease: a 13-year prospective study of the Framingham cohort. Archives of Neurology, 52, 485-490.
56. Loewenstein, D.A., Acevedo, A., Agron, J., & Duara, R. (2007). Stability of neurocognitive impairment in different subtypes of mild cognitive impairment. Dementia and Geriatric Cognitive Disorders, 23, 82-86.
57. Lopes, M.A., & Bottino, C.M.C. (2002). Prevalência de demência em diversas regiões do mundo: análises dos estudos epidemiológicos de 1994 a 2000. Arquivos de Neuropsiquiatria, 60, 61-69.
58. Lopez, O.L., Jagust, W.J., DeKosky, S.T., Becker, J.T., Fitzpatrick, A., Dulberg, C., Breitner, J., Lyketsos, C., Jones, B., Kawas, C., Carlson, M., & Kuller, L.H. (2003). Prevalence and classifcation of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Archives of Neurology, 60, 1385-1389.
59. Luck, T., Luppa, M., Briel, S., & Riedel-Heller, S.G. (2010). Incidence of mild cognitive impairment: a systematic review. Dementia and Geriatric Cognitive Disorders, 29, 164-175.
60. Manly, J.J., Tang, M.X., Schupf, N., Stern, Y., Vonsattel, J.P., & Mayeux, R. (2008). Frequency and course of mild cognitive impairment in a multiethnic community. Annuals of Neurology, 63, 494-506.
61. Mattsson, N., Zetterberg, H., Hansson, O, Andreasen, N., Parnetti, L., Jonsson, M., Herukka, S.K., van der Flier, W.M., Blankenstein, M.A., Ewers, M., Rich, K., Kaiser, E., Verbeek, M., Tsolaki, M., Mulugeta, E., Rosén, E., Aarsland, D., Visser, P.J., Schröder, J., Marcusson, J., de Leon, M., Hampel, H., Scheltens, P., Pirttilä, T., Wallin, A., Jönhagen, M.E., Minthon, L., Winblad, B., & Blennow, K. (2009). CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. Journal of the American Medical Association, 302, 385-393.
62. Meyer, J., Xu, G., Thornby, J. (2002). Longitudinal analysis of abnormal domains comprising mild cognitive impariment (MCI) during aging. Journal of Neurologic Science, 15, 201 (1-2), 19-25.
63. Morris, J.C. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43, 2412-2414.
64. Morris, J.C., Storandt, M., Miller, J.P., McKeel, D.W., Price, J.L., Rubin, E.H., & Berg, L. (2001). Mild cognitive impairment represents early-stage Alzheimer disease. Archives of Neurology, 58, 397-405.
65. Mosconi, L., De Santi, S., Brys, M., Tsui, W.H., Pirraglia, E., Glodzik-Sobanska, L., Rich, K.E., Switalski, R., Mehta, P.D., Pratico, D., Zinkowski, R., Blennow, K., & de Leon, M.J. (2008a). Hypometabolism and altered cerebrospinal fuid markers in normal apolipoprotein E E4 carriers with subjective memory complaints. Biology Psychiatry, 63, 609-618.
66. Mosconi, L., Perani, D., Sorbi, S., Herholz, K., Nacmias, B., Holthoff, V., Salmon, E., Baron, J.C., De Cristofaro, M.T., Padovani, A., Borroni, B., Franceschi, M., Bracco, L., & Pupi, A. (2004). MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology, 63, 2332-2340.
67. 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. Journal of Nuclear Medicine, 49, 390-398.
68. Myers, C.E., Kluger, A., Golomb, J., Gluck, M.A., & Ferris, S. (2008). Learning and generalization tasks predict short-term cognitive outcome in nondemented elderly. Journal of Geriatric Psychiatry and Neurology, 21, 93-103.
69. Negash, L., Greenwood, P.M., Sunderland, T., Parasuraman, R., Geda, Y.E., Knopman, D.S., Boeve, B.F., Ivnik, R.J., Petersen, R.C., & Smith, G.E. (2009). The influence of apolipoprotein E genotype on visuospatial attention dissipates after age 80. Neuropsychology, 23, 81-89.
70. Nitrini, R., Caramelli, P., Herrera, E., Bahia, V.S., Caixeta, L.F., Radanovic, M., Anghinah, R., Charchat-Fichman, H., Porto, Carthery, M.T., Hartmann, A.P., Huang, N., Smid, J., Lima, E.P., Takada, L.T., & Takahashi, D.Y. (2002). Incidence of dementia in a community-dwelling Brazilian population. Neurobiology of Aging, 23(4), 241-246.
71. Nobili, F., Salmaso, D., Morbelli, S., Girtler, N., Piccardo, A., Brugnolo, A., Dessi, B., Larsson, S.A., Rodriguez, G., & Pagani, M. (2008). Principal component analysis of FDG PET in amnestic MCI. European Journal of Nuclear Medicine and Molecular Imaging, 35, 2191-2202.
72. 11C-PIB PET study. Neurology, 73, 754-760.
73. Oliveira, S.F.D., Duarte, Y.A.O., Lebrão, M.L., & Laurenti, R. (2007). Demanda referida e auxílio recebido por idosos com declínio cognitivo no município de São Paulo. Saúde e Sociedade, 16, 81-89.
74. Palmer, K., Bäckman, L., Winglad, B., & Fratiglioni, L. (2008). Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease. American Journal of Geriatric Psychiatry, 16, 603-611.
75. Parasuraman, R., Greenwood, P.M., & Sunderland, T. (2002). The apolipoprotein E gene, attention, and brain function. Neuropsychology, 16, 254-274.
76. Pereira, F.S., Yassuda, M.S., Oliveira, A.M., Diniz, B.S., Radanovic, M., Talib, L.L., Gattaz, W.F., & Forlenza, O.V. (2010). Profles of functional defcits in mild cognitive impairment and dementia: benefts from objective measurement. Journal of International Neuropsychology Society, 16, 297-305.
77. Petersen, R.C., Smith, G.E., Waring, S.C, Ivnik, R.J., Tangalos, E.G., Kokmen E. (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 56, 303-308.
78. Petersen, R.C. (2004). Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine, 256, 183-194.
79. Petersen, R.C., Doody, R., Kurz, A., Mohs, R.C., Morris, J.C., Rabins, P.V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001). Current concepts in mild cognitive impairment. Archives of Neurology, 58, 1985-1992.
80. Petersen, R.C., Parisi, J.E., Dickson, D.W., Johnson, K.A., Knopman, D.S., Boeve, B.F., Jicha, G.A., Ivnik, R.J., Smith, G.E., Tangalos, E.G., Braak, H., & Kokmen, E. (2006). Neuropathologic features of amnestic mild cognitive impairment. Archives of Neurology, 63, 665-672.
81. Petersen, R.C., Roberts, R.O., Knopman, D.S., Boeve, B.F., Geda, Y.E., Ivnik, R.J., Smith, G.E., & Jack, C.R. (2009). Mild cognitive impairment: ten years later. Archives of Neurology, 66, 1447-1455.
82. Petersen, R.C., Smith, G.E., Waring, S.C., Ivnik, R.J., Tangalos, E.G., & Kokmen, E. (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 56, 303-308.
83. Petrella, J.R., Krishnan, S., Slavin, M.J., Tran, T.T., Murty, L., & Doraiswamy, P.M. (2006). Mild cognitive impairment: evaluation with 4-T functional MR imaging. Radiology, 240, 177-186.
84. Plassman, B.L., Langa, K.M., Fisher, G.G., Heeringa, S.T., Weir, D.R., Ofstedal, M.B., Burke, J.R., Hurd, M.D., Potter, G.G., Rodgers, W.L., Steffens, D.C., McArdle, J.J., Willis, R.J., & Wallace, R.B. (2008). Prevalence of cognitive impairment without dementia in the United States. Annals of Internal Medicine, 148, 427-434.
85. Price, J.L, & Morris, J.C. (1999). Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Annals of Neurology, 45, 358-368.
86. Prince, M., Acosta, D., Chiu, H., Scazufca, M., & Varghese, M. (2003). Dementia diagnosis in developing countries: a cross-cultural validation study. Lancet, 361(9361), 909-917.
87. Ramakers, I.H., Visser, P.J., Aalten, P., Bekers, O., Sleegers, K., van Broeckhoven, C.L., Jolles, J., & Verhey, F.R.J. (2008). The association between APOE genotype and memory dysfunction in subjects with mild cognitive impairment is related to age and Alzheimer pathology. Dementia and Geriatric Cognitive Disorders, 26, 101-108.
88. Ramos, L.R., Veras, R.P., & Kalache, A. (1987). Envelhecimento populacional: uma realidade brasileira. Revista de Saúde Pública, 21, 211-224.
89. Rao, V.S., Cupples, A., van Duijn, C.M., Kurz, A., Green, R.C., Chui, H., Duara, R., Auerbach, S.A., Volicer, L., Wells, J., van Broeckhoven, C., Growdon, J.H., Haines, J.L., & Farrer, L.A. (1996). Evidence for major gene inheritance of Alzheimer's Disease in families of patients with and without apolipoprotein Ee4. American Journal of Human Genetics, 59, 664-675.
90. Ravaglia, G., Forti, P., Montesi, F., Lucicesare, A., Pisacane, N., Rietti, E., Dalmonte, E., Bianchin, M., & Mecocci, P. (2007). Mild cognitive impairment: epidemiology and dementia risk in an elderly Italian population. Journal of the American Geriatrics Society, 56, 51-58.
91. Reisberg, B., & Gauthier, S. (2008). Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. International Psychogeriatrics, 20(1), 1-16.
92. Reisberg, B., Ferris, S.H., De Leon, M.J., & Crook, T. (1982). The Global Deterioration Scale for assessment of primary degenerative dementia. American Journal of Psychiatry, 139, 1136-1139.
93. Ridha, B.H., Barnes, J., Bartlett, J.W., Godbolt, A., Pepple, T., Rossor, M.N., & Fox, N.C. (2006). Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study. Lancet Neurology, 5, 828-834.
94. Riemenschneider, M., Lautenschlager, N., Wagenpfeil, S., Diehl, J., Drzezga, A., & Kurz, A. (2002). Cerebrospinal fuid tau and β-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment. Archives of Neurology, 59, 1729-1734.
95. Ries, M.L., Carlson, C.M., Rowley, H.A., Sager, M.A., Gleason, C.E., Asthana, S., & Johnson, S.C. (2008). Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review. Journal American Geriatrics Society, 56, 920-934.
96. Ritchie, K., & Touchon, J. (2000). Mild cognitive impairment: conceptual basis and current nosological status. Lancet, 355, 225-228.
97. Roberts, R.O., Geda, Y.E., Knopman, D.S., Cha, R.H., Pankratz, V.S., Boeve, B.F., Rocca, W.A., & Petersen, R.C. (2008). Men are more likely to have mild cognitive impairment than women: the Mayo Clinic Study of Aging. Neurology, 70(11 Suppl. 1), A225.
98. Rosen, V.M., Sunderland, T., Levy, J., Harwell, A., McGee, L., Hammond, C., Bhupali, D., Putnam, K., Bergeson, J., & Lefkowitz, C. (2005). Apolipoprotein E and category fuency: evidence for reduced semantic access in healthy normal controls at risk for developing Alzheimer's disease. Neuropsychologia, 43, 647-658.
99. Salmon, D.P., Thomas, R.G., Pay, M.M., Booth, A., Hofstetter, C.R., Thal, L.J., & Katzman, R. (2002). Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals. Neurology, 59, 1022-1028.
100. Seo, S.W., Im, K., Lee, J.M., Kim, Y.H., Kim, S.T., Kim, S.Y., Yang, D.W., Kim, S.I., Cho, Y.S., & Na, D.L. (2007). Cortical thickness in single- versus multiple-domain amnestic mild cognitive impairment. Neuroimage, 36, 289-297.
101. Shaw, L.M., Vanderstichele, H., Knapik-Czajka, M., Clark, C.M., Aisen, P.S., Petersen, R.C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., Dean, R., Siemers, E., Potter, W., Lee, V.M.Y., & Trojanowski, J.Q. (2009). Cerebrospinal fuid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Annals of Neurology, 65, 403-413.
102. Singh, V., Chertkow, H., Lerch, J.P., Evans, A.C., Dorr, A.E., & Kabani, N.J. (2006). Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease. Brain, 129, 2885-2893.
103. Small, B.J., Fratiglioni, L., Viitanen, M., Winblad, B., & Backman, L. (2000). The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Archives of Neurology, 57, 839-844.
104. Solfrizzi, V., Colacicco, A.M., D'Introno, A., Capurso, C., Del Parigi, A., Capurso, S.A., Argentieri, G., Capurso, A., & Panza, F. (2006). Dietary fatty acids intakes and rate of mild cognitive impairment: the Italian Longitudinal Study on Aging. Experimental Gerontology, 41, 619-627.
105. Solfrizzi, V., Panza, F., Colacicco, A.M., D'Introno, A., Capurso, C., Torres, F., Grigoletto, F., Maggi, S., Del Parigi, A., Reiman, E.M., Caselli, R.J., Scafato, E., Farchi, G., & Capurso, A. (2004). Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology, 63, 1882-1891.
106. Squire, L. (1986). Mechanisms of memory. Science, 232, 1612-1619.
107. Tapiola, T., Pennanen, C., Tapiola, M., Tervo, S., Kivipelto, M., Hänninen, T., Pihlajamäki, M., Laakso, M.P., Hallikainen, M., Hämäläinen, A., Vanhanen, M., Helkala, E.L., Vanninen, R., Nissinen, A., Rossi, R., Frisoni, G.B., & Soininen, H. (2008). MRI of hippocampus and entorhinal cortex in mild cognitive impairment: a follow-up study. Neurobiology of Aging, 29, 31-38.
108. Tervo, S., Kivipelto, M., Hanninen, T., Vanhanen, M., Hallikainen, M., Mannermaa, A., & Soininen, H. (2004). Incidence and risk factors for mild cognitive impairment: a population based three-year follow-up study of cognitively healthy elderly subjects. Dementia and Geriatric Cognitive Disorders, 17, 196-203.
109. Tierney, M.C., Szalai, J.P., Snow, W.G., Fisher, R.H., Nores, A., Nadon, G., Dunn, E., & George-Hyslop, P.H. (1996). Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology, 46, 661-665.
110. Touchon, J., & Ritchie, K. (1999). Prodromal cognitive disorder in Alzheimer's disease. International Journal of Geriatric Psychiatry, 14, 556-563.
111. Trojanowski, J.Q., Vandeerstichele, H., Korecka, M., Clark, C.M., Aisen, P.S., Petersen, R.C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., Dean, R., Siemers, E., Potter, W.Z., Weiner, M.W., Jack, C.R., Jagust, W., Toga, A.W., Lee, V.M., & Shaw, L.M. (2010). Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimer's and Dementia, 6, 230-238.
112. Tschanz, J.T., Welsh-Bohmer, K.A., Lyketsos, C.G., Corcoran, C., Green, R.C., Hayden, K., Norton, M.C., Zandi, P.P., Toone, L., West, N.A., & Breitner, J.C. (2006). Conversion to dementia from mild cognitive disorder: the Cache County Study. Neurology, 67, 229-234.
113. Tulving, E. (1995). Organization of memory: quo vadis? In S. Gazzaniga (Ed.), The cognitive neurosciences (pp. 839-847). Cambridge, MA: MIT Press.
114. Unverzagt, F.W., Gao, S., Baiyewu, O, Ogunniyi, A.O., Gureje, O., Perkins, A., Emsley, C.L., Dickens, J., Evans, R., Musick, B., Hall, K.S., Hui, S.L., & Hendrie, H.C. (2001). Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging. Neurology, 57, 1655-1662.
115. Verghese, J., LeValley, A., Derby, C., Kuslansky, G., Katz, M., Hall, C., Buschke, H., & Lipton, R.B. (2006). Leisure activities and the risk of amnestic mild cognitive impairment in the elderly. Neurology, 66, 821-827.
116. Visser, P.J., Verhey, F.R., Scheltens, P., Cruts, M., Ponds, R.W., Van Broeckhoven, C.L., & Jolles, J. (2002). Diagnostic accuracy of the Preclinical AD Scale (PAS) in cognitively mildly impaired subjects. Journal of Neurology, 249, 312-319.
117. Wiltfang, J., Lewczuk, P., Riederer, P., Grünblatt, E., Hock, C., Scheltens, P., Hampel, H., Vanderstichele, H., Iqbal, K., Galasko, D., Lannfelt, L., Otto, M., Esselmann, H., Henkel, A.W., Kornhuber, J., & Blennow, K. (2005). Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia. World Journal of Biological Psychiatry, 6, 69-84.
118. Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L.O., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., Arai, H., Basun, H., Blennow, K., de Leon, M., DeCarli, C., Erkinjuntti, T., Giacobini, E., Graff, C., Hardy, J., Jack, C., Jorm, A., Ritchie, K., van Duijn, C., Visser, P., & Petersen, R.C. (2004). Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine, 256, 240-246.
119. Wishart, H.A., Saykin, A.J., Rabin, L.A., Santulli, R.B., Flashman, L.A., Guerin, S.J., Mamourian, A.C., Belloni, D.R., Rhodes, C.H., & McAllister, T.W. (2006). Increased brain activation during working memory in cognitively intact adults with the APOE e4 allele. American Journal Psychiatry, 163, 1603-1610.
120. World Health Organization (1993). The ICD-10 classifcation of mental and behavioural disorders: diagnostic criteria for research. Geneva: World Health Organization.
121. World Health Organization (2009). Ageing (http://www.who.int/ topics/ageing/en/; accessed September 21, 2011).
122. Yaffe, K., Petersen, R.C., Lindquist, K., Kramer, J., Miller, B. (2006). Subtype of mild cognitive impairment and progression to dementia and death. Dementia and Geriatric Cognitive Disorders, 22(4), 312-319.
123. Yaffe, K., Middleton, L.E., Lui, L.Y., Spira, A.P., Stone, K., Racine, C., Ensrud, K.E., & Kramer, J.H. (2011a). Mild cognitive impairment, dementia, and their subtypes in oldest old women. Archives of Neurology, 68, 631-636.
124. Zhang, D., Wang, Y., Zhou, L., Yuan, H., & Shen, D. (2011). Multimodal classifcation of Alzheimer's disease and mild cognitive impairment. Neuroimage, 55, 856-867.